Petersen, Christian Hunnicke
Mahmood, Badar
Badsted, Christoffer
Dahlby, Tina
Rasmussen, Hanne Borger
Hansen, Mark Berner
Bindslev, Niels
Funding for this research was provided by:
The Danish Cancer Society (R141-A8964-15-S7)
Else and Mogens Wedell-Wedellborgs Foundation (30-17-1)
Civilingeniør Bent Bøgh og Hustru Inge Bøghs Fond (Award number not provided by funder)
Article History
Received: 19 June 2018
Accepted: 13 June 2019
First Online: 28 June 2019
Ethics approval and consent to participate
: The study protocol was approved by The Scientific Ethical Committee of Copenhagen (H32013107) and The Danish Data Protection Agency (BBH-2013-024, I-Suite nr: 02342) and conducted in accordance with the Helsinki declaration. All patients participating gave prior informed written consent.
: Not applicable.
: Mark Berner-Hansen was also an employee at Zealand Pharma, Denmark. All authors have no conflict of interest related to the present study.